August 6, 2025 · Form 4 insider transaction
Guidroz Allyson bought 2,015 shares of Amedisys, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
The Issuer awarded the Reporting Person 2,015 time-based RSUs, each of which represents a contingent right to receive one share of the Issuer's common stock, and will vest 50% on each of August 6, 2026 and August 6, 2027, provided that the Reporting Person remains continuously employed by the Issuer on each such date.